Study of Magnetic Fields to Treat Alzheimer's Disease
NCT01313806 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2011-05-30
Summary
To determine if low level magnetic fields can help to improve memory in patients diagnosed with Alzheimer's disease.
Conditions
Interventions
- DEVICE
-
Resonator
Treatment group vs. Placebo group
- DEVICE
-
Placebo
Inactive Resonator Device
Sponsors & Collaborators
-
pico-tesla Magnetic Therapies, LLC
lead INDUSTRY
Principal Investigators
-
Jack A Klapper, MD · Mile High Research Center
-
Miguel Trevino, MD · Innovative Research of West Florida
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2012-09-30
- Completion
- 2012-09-30
Countries
- United States
Study Locations
More Related Trials
-
Neurostimulation for Cognitive Enhancement in Alzheimer's Disease
NCT04404153 ·Status: COMPLETED ·Phase: NA
-
Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
NCT02190084 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
NCT00930059 ·Status: COMPLETED ·Phase: PHASE2
-
Low Dose Ionizing Radiation Using CT Scans as a Potential Therapy for Alzheimer's Dementia: A Pilot Study
NCT03597360 ·Status: COMPLETED ·Phase: NA
-
Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease
NCT02811653 ·Status: UNKNOWN ·Phase: NA
-
An Evaluation of Low Level Laser Light Therapy on Improving the Symptoms of Alzheimer's Disease
NCT02537626 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease
NCT03289143 ·Status: TERMINATED ·Phase: PHASE2
-
Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG
NCT04735536 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of Transcranial Focused Ultrasound for the Treatment of Neurodegenerative Dementias
NCT04250376 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD
NCT04191486 ·Status: COMPLETED ·Phase: PHASE2
-
Zydena on Cognitive Function of Alzheimer's Disease Patients
NCT01940952 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease
NCT00933608 ·Status: COMPLETED ·Phase: PHASE4
-
Study in Subjects With Mild-to-Moderate Alzheimer's Dementia
NCT05834296 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Impact of a Biophoton Therapy on Patients With Brain Disorders
NCT06147999 ·Status: RECRUITING ·Phase: NA
-
A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease
NCT01807026 ·Status: COMPLETED ·Phase: PHASE1
-
TNF-Alpha Inhibition for Treatment of Alzheimer's Disease
NCT00203359 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility Study of Transcranial Ultrasound Stimulation on Alzheimer's Disease Patients
NCT03896698 ·Status: UNKNOWN ·Phase: NA
-
Electrophysiologic Measures of Treatment Response in Alzheimer Disease
NCT00018278 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Evaluate the Efficacy and Security of Deep Brain Stimulation in Alzheimer´s Disease
NCT03290274 ·Status: UNKNOWN ·Phase: NA
-
Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease
NCT02955706 ·Status: COMPLETED ·Phase: PHASE4
-
Applying PET/MR for Dementia Applications
NCT04154254 ·Status: UNKNOWN ·Phase: NA
-
Alzheimer's Tau Platform: Master Protocol
NCT06957418 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease
NCT03462121 ·Status: COMPLETED ·Phase: PHASE2
-
Using Hypnotherapy For Dementia & Alzheimer's
NCT01435551 ·Status: NO_LONGER_AVAILABLE
-
A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease
NCT03765762 ·Status: COMPLETED ·Phase: PHASE2